Form 4: Moleculin Biotech Executive Buys Shares
Insider Transaction (Form 4)
Donald H Picker, Chief Science Officer of Moleculin Biotech, Inc., purchased 693,332 shares of common stock on August 3, 2026.
Summary
- Open-market purchase: acquired 173,333 Common Stock on August 3, 2026; holds 174,086 after (Direct).
- Open-market purchase: acquired 519,999 Series I Warrants on August 3, 2026; holds 539,595 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $0, committing personal capital to the stock.
Insider Transactions
Donald H Picker — Officer (Chief Science Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-03 | Open-market purchase | Common Stock | 173,333 | — | — | 174,086 |
| 2026-08-03 | Open-market purchase | Series I Warrants | 519,999 | — | — | 539,595 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-03 | Open-market purchase (173,333 shares) |
| 2026-08-03 | Open-market purchase (519,999 shares) |
Keywords
insider transaction, Form 4, MBRX, Moleculin Biotech, Inc., bullish, Donald H Picker
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.